# OMass Therapeutics

**Canonical:** https://apis.io/providers/omass-therapeutics/  
**Website:** https://www.omass.com  
**APIs profiled:** 0

OMass Therapeutics is an Oxford, UK biotechnology company developing medicines for immunological and rare diseases. It harnesses proprietary biochemistry, native mass spectrometry and custom chemistry through its OdyssION drug discovery platform to interrogate drug targets and how they interact with their native biological ecosystem, separate from the confounding complexity of the cell. The company operates a corporate and scientific web presence (science, pipeline, publications, news and blog) and, as a therapeutics company, publishes no public developer or API surface. Backed by GV and other life-sciences investors.

## Kin Score — 3.8 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.8).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Omass Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Life Sciences, Biotechnology, Pharmaceuticals, Drug Discovery, Mass Spectrometry, Immunology, Rare Diseases

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/omass-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.